Treatment with the SGLT2 inhibitor luseogliflozin improves nonalcoholic steatohepatitis in a rodent model with diabetes mellitus
2015 · Diabetology & Metabolic Syndrome · 112 citations
https://doi.org/10.1186/s13098-015-0102-8
A
Akifumi Kushiyama
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
137
Papers
3.4K
Citations
35
h-index
76
i10-index
Akifumi Kushiyama is an academic researcher from Meiji Pharmaceutical University. The author has contributed to research in topics: Pancreatic function and diabetes & Signaling Pathways in Disease & Metabolism, Diabetes, and Cancer. The author has an h-index of 35, co-authored 117 publications.
ORCID: 0000-0003-1385-7487Papers by this author
worksProlyl Isomerase Pin1 Negatively Regulates AMP-activated Protein Kinase (AMPK) by Associating with the CBS Domain in the γ Subunit
2015 · Journal of Biological Chemistry · 38 citations
https://doi.org/10.1074/jbc.m115.658559
Role of Pin1 Protein in the Pathogenesis of Nonalcoholic Steatohepatitis in a Rodent Model
2012 · Journal of Biological Chemistry · 34 citations
https://doi.org/10.1074/jbc.m112.397133
Prolyl Isomerase Pin1 Suppresses Thermogenic Programs in Adipocytes by Promoting Degradation of Transcriptional Co-activator PRDM16
2019 · Cell Reports · 24 citations
https://doi.org/10.1016/j.celrep.2019.02.066
Par14 Protein Associates with Insulin Receptor Substrate 1 (IRS-1), Thereby Enhancing Insulin-induced IRS-1 Phosphorylation and Metabolic Actions
2013 · Journal of Biological Chemistry · 21 citations
https://doi.org/10.1074/jbc.m113.485730
Quantitative sonographic assessment of quadriceps muscle thickness for fall injury prediction in patients undergoing maintenance hemodialysis: an observational cohort study
2021 · BMC Nephrology · 20 citations
https://doi.org/10.1186/s12882-021-02347-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat